24 January 2012 - Genzyme Corp, a subsidiary of France's Sanofi SA (EPA:SAN), said on Tuesday that the US Food and Drug Administration (FDA) had given the green light for the launch of production of Fabrazyme (agalsidase beta) at the company's manufacturing plant in Framingham, Massachuset...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up